What Is the Optimal Second-Line Antidiabetic Regimen To Delay the Onset of Microvascular Complications? Application of a Marginal Structural Model

Research output: Contribution to conferencePoster

Original languageEnglish
Pages1-587
Number of pages587
Publication statusPublished - 2015
Event31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Hynes Convention Center, Boston, USA
Duration: 22 Aug 201526 Aug 2015

Conference

Conference31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management
CityHynes Convention Center, Boston, USA
Period22/08/1526/08/15

Cite this